<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00716560</url>
  </required_header>
  <id_info>
    <org_study_id>05C.202</org_study_id>
    <secondary_id>2004-101</secondary_id>
    <secondary_id>0402005015</secondary_id>
    <nct_id>NCT00716560</nct_id>
  </id_info>
  <brief_title>Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin</brief_title>
  <official_title>Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Cancer Center at Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the incidence of nausea with systemic chemotherapy
      that includes consecutive days (more than one day)of cisplatin medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth
      regimen.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Administratively terminated.
  </why_stopped>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Determine incidence of nausea when receiving Dartmouth regimen chemotherapy for metastatic melanoma</measure>
    <time_frame>Week of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the impact of systemic chemotherapy with Dartmouth regimen on quality of life of patients</measure>
    <time_frame>week of treatment</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8</enrollment>
  <condition>Metastatic Melanoma</condition>
  <condition>Nausea</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Metastatic melanoma treatment with Dartmouth regimen</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        University practice patients with metastatic melanoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed diagnosis metastatic melanoma

          -  18 years and older

          -  undergoing chemotherapy with Dartmouth regimen

          -  medically stable to receive chemotherapy per physical and clinical laboratory tests

        Exclusion Criteria:

          -  No medical conditions that interfere with assessment of nausea and vomiting during
             chemotherapy

          -  No cognitive disorder that impairs symptom assessment

          -  No other investigational agent

          -  Inability to swallow medications for nausea and vomiting

          -  No gastric outlet obstruction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takami Sato, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.KimmelCancerCenter.org</url>
    <description>Kimmel Cancer Center at Thomas Jefferson University</description>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2008</study_first_submitted>
  <study_first_submitted_qc>July 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2008</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

